Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gastroesophageal Reflux Disease (GERD) Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.